TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04322084

Continuous Ambulatory Monitoring to Predict Elevated Risk of Infection in Children With Lymphoblastic Leukemia Undergoing Induction Chemotherapy (CAMPER-ALL)

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“The study was activated at the onset of the COVID pandemic. At that time voluntary, non-therapeutic research was placed on hold. Now the technology has evolved and have elected to forego this protocol.”

The sponsor’s own words in the registry.

Life of this trial

202020212022202320242025Registered2020-03-23Planned start2024-09 (planned)Withdrawn (as of)2024-09-25

Vital statistics

Status
Withdrawn
Sponsor
St. Jude Children's Research Hospital
Sponsor type
University, hospital or other
Conditions
Acute Lymphoblastic Leukemia
Interventions
Wearable Sensors
Participants
0
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.